New Webinar
ViroGates and Hellenic Institute for the Study of Sepsis announces positive topline results from the investigator-sponsored SAVE-MORE randomised controlled trial, evaluating early and targeted use of suPAR-guided anakinra treatment in over 600 patients. The [...]
Our annual report for 2020 has just been published In 2020, we made promising progress despite the challenging circumstances caused by the COVID-19 pandemic. We have been able to establish a more robust platform with [...]
suPAR on DR2 Our CEO Jakob Knudsen participated in an experiment for the Danish TV channel DR2, where he and a few others tested Wim Hof’s techniques, consisting of cold baths and breathing exercises that should strengthen the [...]
Policlínica Nuestra Señora del Rosario is the newest addition to our list of already established customers in Spain. The customer is a private hospital located in Ibiza. The hospital has around 70 beds offering both acute care treatment and [...]
suPARnostic® can become the first companion diagnostic device to aid in selecting and excluding COVID-19 patient groups for drug treatment. The product is already deployed for risk stratification and patient management of COVID-19 patients in European hospitals. We have [...]
Mikkeli Central Hospital has decided to implement suPARnostic® TurbiLatex in clinical routine, making them the first clinical routine customer in Finland. Mikkeli is the central hospital in Mikkeli and has an uptake population of about 100,000 inhabitants and approx. [...]
The University Hospital of Salamanca is the newest costumer in Spain that will be using suPARnostic® TurbiLatex in clinical routine. The hospital's decision to implement our product to improve their triage follows a process of pilot use of suPARnostic® [...]
suPARnostic® TurbiLatex will now be available for clinical decision making in the Emergency Department of Hospital Clínico Universitario Virgen de la Arrixaca, located in the Murcia region in Spain. The hospital has started to use [...]
If you have any questions regarding our products or business, write to us here
